Allogene CFO Geoffrey Parker to retire effective Nov. 6
Allogene Therapeutics said CFO Geoffrey Parker will retire effective Nov. 6, adding to leadership changes after Zachary Roberts was elevated to chief executive.
By Robb M.
StewartAllogene Therapeutics Chief Financial Officer Geoffrey Parker will retire later this year, adding to the changes at the top for the biotechnology company after Zachary Roberts was elevated to chief executive.The San Francisco-based company said Parker will retire effective Nov.
6…